Based on the Tiziana Life Sciences Ltd stock forecast from 0 analysts, the average analyst target price for Tiziana Life Sciences Ltd is not available over the next 12 months. Tiziana Life Sciences Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Tiziana Life Sciences Ltd is Very Bearish, which is based on 0 positive signals and 8 negative signals. At the last closing, Tiziana Life Sciences Ltd’s stock price was USD 0.96. Tiziana Life Sciences Ltd’s stock price has changed by -6.81% over the past week, -3.07% over the past month and +74.53% over the last year.
No recent analyst target price found for Tiziana Life Sciences Ltd
No recent average analyst rating found for Tiziana Life Sciences Ltd
Company Overview Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), an orally bioavailable small molecule broad spectrum inhibitor of various cyclin-dependent kinases and Src family; and TZLS-501, a fully human mAb targeting the IL-6 receptor for the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom. Read Less
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclon...Read More
Frequently Asked Questions About Tiziana Life Sciences Ltd (TLSA) Stock
Stock Target Advisor's fundamental analysis for Tiziana Life Sciences Ltd's stock is Very Bearish.
Unfortunately we do not have enough data on TLSA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TLSA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on TLSA's stock to indicate if its overvalued.
The last closing price of TLSA's stock was USD 0.96.
The most recent market capitalization for TLSA is USD 0.10B.
Unfortunately we do not have enough analyst data on TLSA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Tiziana Life Sciences Ltd's stock.
As per our most recent records Tiziana Life Sciences Ltd has 9 Employees.
Tiziana Life Sciences Ltd's registered address is 14/15 Conduit Street, London, United Kingdom, W1S 2XJ.
You can get more information about it from Tiziana Life Sciences Ltd's website at https://www.tizianalifesciences.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Tiziana Life Sciences Ltd (TLSA) Stock
Stock Target Advisor's fundamental analysis for Tiziana Life Sciences Ltd's stock is Very Bearish.
Unfortunately we do not have enough data on TLSA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TLSA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on TLSA's stock to indicate if its overvalued.
The last closing price of TLSA's stock was USD 0.96.
The most recent market capitalization for TLSA is USD 0.10B.
Unfortunately we do not have enough analyst data on TLSA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Tiziana Life Sciences Ltd's stock.
As per our most recent records Tiziana Life Sciences Ltd has 9 Employees.
Tiziana Life Sciences Ltd's registered address is 14/15 Conduit Street, London, United Kingdom, W1S 2XJ.
You can get more information about it from Tiziana Life Sciences Ltd's website at https://www.tizianalifesciences.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TLSA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
